Success Metrics

Clinical Success Rate

100.0%

Based on 3 completed trials

Completion Rate

100%(3/3)

Active Trials

0(0%)

Results Posted

67%(2 trials)

Phase Distribution

Ph phase_3

25%

Ph phase_2

75%

Phase Distribution

Early Stage

Mid Stage

Late Stage

Phase Distribution4 total trials

Phase 2Efficacy & side effects

3(75.0%)

Phase 3Large-scale testing

1(25.0%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

75.0%

3 of 4 finished

Non-Completion Rate

25.0%

1 ended early

Currently Active

trials recruiting

Total Trials

all time

Status Distribution

Completed(3)

Terminated(1)

Detailed Status

Completed3

Withdrawn1

Development Timeline

Analytics

Development Status

Total Trials

Active

Success Rate

100.0%

Most Advanced

Phase 3

Trials by Phase

Phase 23 (75.0%)

Phase 31 (25.0%)

Trials by Status

withdrawn125%

completed375%

Recent Activity

0 active trials

Showing 4 of 4

completedphase_2

Study of Debio 1450 for Bacterial Skin Infections

NCT02426918

completedphase_2

GSK1322322 Versus Linezolid in the Treatment of Acute Bacterial Skin and Skin Structure Infection

NCT01209078

withdrawnphase_3

A P3 Comparator Trial in Community Acquired Bacterial Pneumonia

NCT02269644

completedphase_2

Efficacy and Safety Study of JNJ-32729463 for Treating Complicated Skin and Skin Structure Infections Compared to Linezolid (Zyvox)

NCT01128530

Clinical Trials (4)

Showing 4 of 4 trials

NCT02426918Phase 2

Study of Debio 1450 for Bacterial Skin Infections

Completed

NCT01209078Phase 2

GSK1322322 Versus Linezolid in the Treatment of Acute Bacterial Skin and Skin Structure Infection

Completed

NCT02269644Phase 3

A P3 Comparator Trial in Community Acquired Bacterial Pneumonia

Withdrawn

NCT01128530Phase 2

Efficacy and Safety Study of JNJ-32729463 for Treating Complicated Skin and Skin Structure Infections Compared to Linezolid (Zyvox)

Completed

All 4 trials loaded

Drug Details

Intervention Type: DRUG
Total Trials: 4